• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PI31是蛋白酶体形成和抗原加工的调节剂。

PI31 is a modulator of proteasome formation and antigen processing.

作者信息

Zaiss Dietmar M W, Standera Sybille, Kloetzel Peter-M, Sijts Alice J A M

机构信息

Institute of Biochemistry, Medical Faculty Charité, Humboldt University, D-10117 Berlin, Germany.

出版信息

Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14344-9. doi: 10.1073/pnas.212257299. Epub 2002 Oct 8.

DOI:10.1073/pnas.212257299
PMID:12374861
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC137886/
Abstract

Regulation of the proteasome system, which is responsible for the generation of most MHC class I-bound peptides, occurs through the interaction of the 20S proteasome with several regulatory proteins. One of these is PI31, which acts in vitro as an inhibitor of proteasome activity. Here, we demonstrate that, rather than inhibiting proteasome function, PI31 acts as a selective modulator of the proteasome-mediated steps in MHC class I antigen processing. Overexpression of PI31 in mouse embryonic cells has no impact on proteasome-mediated proteolysis. Instead, PI31, which localizes at the nuclear envelope/endoplasmic reticulum membrane, selectively interferes with the maturation of immunoproteasome precursor complexes. Consequently, overexpression of PI31 abrogates MHC class I presentation of an immunoproteasome-dependent cytotoxic T lymphocyte epitope and reduces the surface MHC class I levels on IFN-gamma-treated mouse embryonic cells. Thus, PI31 represents a cellular regulator of proteasome formation and of proteasome-mediated antigen processing.

摘要

蛋白酶体系统负责生成大多数与MHC I类分子结合的肽段,该系统的调节是通过20S蛋白酶体与几种调节蛋白的相互作用实现的。其中之一是PI31,它在体外作为蛋白酶体活性的抑制剂发挥作用。在此,我们证明,PI31并非抑制蛋白酶体功能,而是作为蛋白酶体介导的MHC I类抗原加工步骤的选择性调节剂。PI31在小鼠胚胎细胞中的过表达对蛋白酶体介导的蛋白水解没有影响。相反,定位于核膜/内质网膜的PI31选择性地干扰免疫蛋白酶体前体复合物的成熟。因此,PI31的过表达消除了免疫蛋白酶体依赖性细胞毒性T淋巴细胞表位的MHC I类呈递,并降低了经γ干扰素处理的小鼠胚胎细胞表面MHC I类分子的水平。因此,PI31代表了蛋白酶体形成和蛋白酶体介导的抗原加工的细胞调节剂。

相似文献

1
PI31 is a modulator of proteasome formation and antigen processing.PI31是蛋白酶体形成和抗原加工的调节剂。
Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14344-9. doi: 10.1073/pnas.212257299. Epub 2002 Oct 8.
2
Potential roles of protein oxidation and the immunoproteasome in MHC class I antigen presentation: the 'PrOxI' hypothesis.蛋白质氧化和免疫蛋白酶体在MHC I类抗原呈递中的潜在作用:“PrOxI”假说
Arch Biochem Biophys. 2004 Mar 1;423(1):88-96. doi: 10.1016/j.abb.2003.12.001.
3
Expression of the proteasome activator PA28 rescues the presentation of a cytotoxic T lymphocyte epitope on melanoma cells.蛋白酶体激活剂PA28的表达可挽救黑色素瘤细胞上细胞毒性T淋巴细胞表位的呈递。
Cancer Res. 2002 May 15;62(10):2875-82.
4
A role for the proteasome regulator PA28alpha in antigen presentation.蛋白酶体调节剂PA28α在抗原呈递中的作用。
Nature. 1996 May 9;381(6578):166-8. doi: 10.1038/381166a0.
5
Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing.干扰素-γ、泛素-蛋白酶体系统的功能可塑性与MHC I类抗原加工
Immunol Rev. 2005 Oct;207:19-30. doi: 10.1111/j.0105-2896.2005.00308.x.
6
The role of the proteasome system and the proteasome activator PA28 complex in the cellular immune response.蛋白酶体系统及蛋白酶体激活剂PA28复合物在细胞免疫应答中的作用。
Biol Chem. 1999 Mar;380(3):293-7. doi: 10.1515/BC.1999.040.
7
Proteasome activity limits the assembly of MHC class I molecules after IFN-gamma stimulation.蛋白酶体活性限制了γ干扰素刺激后MHC I类分子的组装。
J Immunol. 1997 Dec 15;159(12):5896-904.
8
The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors: involvement of nonproteasomal cytosolic proteases in antigen processing?蛋白酶体抑制剂仅部分抑制与MHC I类相关肽的产生:非蛋白酶体胞质蛋白酶参与抗原加工?
J Immunol. 1997 Jul 15;159(2):554-64.
9
Abnormal IFN-gamma-dependent immunoproteasome modulation by Trypanosoma cruzi-infected macrophages.克氏锥虫感染的巨噬细胞对干扰素-γ依赖性免疫蛋白酶体的异常调节
Parasite Immunol. 2008 May;30(5):280-92. doi: 10.1111/j.1365-3024.2008.01022.x. Epub 2008 Feb 25.
10
Selective involvement of proteasomes and cysteine proteases in MHC class I antigen presentation.蛋白酶体和半胱氨酸蛋白酶在MHC I类抗原呈递中的选择性参与。
J Immunol. 1997 Dec 15;159(12):5769-72.

引用本文的文献

1
GIGYF2: A Multifunctional Regulator at the Crossroads of Gene Expression, mRNA Surveillance, and Human Disease.GIGYF2:基因表达、mRNA监测与人类疾病交叉路口的多功能调节因子
Cells. 2025 Jul 5;14(13):1032. doi: 10.3390/cells14131032.
2
PI31 is a positive regulator of 20S immunoproteasome assembly.PI31是20S免疫蛋白酶体组装的正向调节因子。
J Cell Sci. 2025 May 15;138(10). doi: 10.1242/jcs.263887. Epub 2025 May 23.
3
Mechanisms of ubiquitin-independent proteasomal degradation and their roles in age-related neurodegenerative disease.不依赖泛素的蛋白酶体降解机制及其在年龄相关性神经退行性疾病中的作用。
Front Cell Dev Biol. 2025 Feb 7;12:1531797. doi: 10.3389/fcell.2024.1531797. eCollection 2024.
4
PI31 is a positive regulator of 20S immunoproteasome assembly.PI31是20S免疫蛋白酶体组装的正向调节因子。
bioRxiv. 2025 Jan 15:2025.01.15.633194. doi: 10.1101/2025.01.15.633194.
5
Dynll1-PI31 Interaction Enhances Proteolysis Through the Proteasome, Representing a Novel Therapeutic Target for INF2-Related FSGS.Dynll1与PI31的相互作用通过蛋白酶体增强蛋白水解作用,是与INF2相关的局灶节段性肾小球硬化症的新型治疗靶点。
Kidney360. 2025 Jan 1;6(1):38-48. doi: 10.34067/KID.0000000659. Epub 2024 Dec 2.
6
Mechanisms and regulation of substrate degradation by the 26S proteasome.26S蛋白酶体对底物降解的机制与调控
Nat Rev Mol Cell Biol. 2025 Feb;26(2):104-122. doi: 10.1038/s41580-024-00778-0. Epub 2024 Oct 3.
7
Differential Interactions of the Proteasome Inhibitor PI31 with Constitutive and Immuno-20S Proteasomes.蛋白酶体抑制剂 PI31 与组成型和免疫 20S 蛋白酶体的差异相互作用。
Biochemistry. 2024 Apr 16;63(8):1000-1015. doi: 10.1021/acs.biochem.3c00707. Epub 2024 Apr 5.
8
The Ubiquitin-Proteasome System in Immune Cells.免疫细胞中的泛素-蛋白酶体系统。
Biomolecules. 2021 Jan 5;11(1):60. doi: 10.3390/biom11010060.
9
Structure, Dynamics and Function of the 26S Proteasome.26S 蛋白酶体的结构、动态与功能。
Subcell Biochem. 2021;96:1-151. doi: 10.1007/978-3-030-58971-4_1.
10
A Conserved Requirement for During Male Germ Cell Cytoplasmic Remodeling.在雄性生殖细胞胞质重塑过程中对……的保守需求。 (原文中“for”后面似乎缺失了关键信息)
Front Physiol. 2019 Oct 10;10:1278. doi: 10.3389/fphys.2019.01278. eCollection 2019.

本文引用的文献

1
Protein degradation and the generation of MHC class I-presented peptides.蛋白质降解与MHC I类呈递肽的产生
Adv Immunol. 2002;80:1-70. doi: 10.1016/s0065-2776(02)80012-8.
2
The role of the ubiquitin-proteasome pathway in MHC class I antigen processing: implications for vaccine design.泛素-蛋白酶体途径在MHC I类抗原加工中的作用:对疫苗设计的启示。
Curr Mol Med. 2001 Dec;1(6):665-76. doi: 10.2174/1566524013363230.
3
Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules.制造天然的基因芯片:用于由I类主要组织相容性复合体分子呈递的肽段的生成
Annu Rev Immunol. 2002;20:463-93. doi: 10.1146/annurev.immunol.20.100301.064819. Epub 2001 Oct 4.
4
Immunoproteasome assembly and antigen presentation in mice lacking both PA28alpha and PA28beta.缺乏PA28α和PA28β的小鼠中的免疫蛋白酶体组装和抗原呈递
EMBO J. 2001 Nov 1;20(21):5898-907. doi: 10.1093/emboj/20.21.5898.
5
Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products.通过对裂解产物的定量分析揭示组成型和免疫蛋白酶体的离散裂解基序。
J Exp Med. 2001 Jul 2;194(1):1-12. doi: 10.1084/jem.194.1.1.
6
Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens.免疫蛋白酶体在T细胞库和病毒抗原呈递水平上塑造抗病毒CD8(+) T细胞的免疫显性层次结构。
J Exp Med. 2001 Jun 4;193(11):1319-26. doi: 10.1084/jem.193.11.1319.
7
26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide.26S蛋白酶体和免疫蛋白酶体主要产生抗原肽的N端延伸版本。
EMBO J. 2001 May 15;20(10):2357-66. doi: 10.1093/emboj/20.10.2357.
8
Mechanisms of ubiquitin-mediated, limited processing of the NF-kappaB1 precursor protein p105.泛素介导的NF-κB1前体蛋白p105有限加工的机制
Biochimie. 2001 Mar-Apr;83(3-4):341-9. doi: 10.1016/s0300-9084(01)01239-1.
9
Antigen processing by the proteasome.蛋白酶体对抗原的处理
Nat Rev Mol Cell Biol. 2001 Mar;2(3):179-87. doi: 10.1038/35056572.
10
Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28.蛋白酶体免疫亚基或PA28的可控表达对细胞毒性T淋巴细胞表位呈递的差异影响
J Exp Med. 2000 Aug 21;192(4):483-94. doi: 10.1084/jem.192.4.483.